MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
October 21, 2021

Rituximab-Based Treatment Safe, Effective for Very Elderly Patients With Aggressive DLBCL

By Cameron Kelsall, MD /alert Contributor
A joint retrospective and prospective study presented at the 2021 ESMO Congress confirmed the safety and efficacy of rituximab, given in combination with non-pegylated liposomal doxorubicin, as a treatment for patients with diffuse large B-cell lymphoma (DLBCL) who are aged 80 years or older...
Rituximab-Based Treatment Safe, Effective for Very Elderly Patients With Aggressive DLBCL
October 20, 2021

Recommendations from SITC and AACR on Investigating Immune-Related Adverse Events

By Mara Shapiro, Staff Writer

Experts from the Society of Immunotherapy of Cancer (SITC) and the American Association for Cancer Research (AACR) are calling for a greater collective understanding of immune-related adverse events following cancer treatment with immunotherapy and how best to manage them so that all eligible patients can benefit from immunotherapy...
Recommendations from SITC and AACR on Investigating Immune-Related Adverse Events
October 19, 2021

FDA Clears Investigational Multiple Myeloma Treatment for Trial

By Adam Hochron, Staff Writer
The FDA has cleared an investigational treatment for multiple myeloma to be used in a clinical trial...
FDA Clears Investigational Multiple Myeloma Treatment for Trial
October 18, 2021

Lone Patient Outcome Prompts FDA Hold on ALPHA2 CAR-T Trial

By Mara Shapiro, Staff Writer

The FDA has put the alloCAR T clinical trials on hold pending investigation after one patient presented with a chromosomal abnormality in ALLO-501A CAR T cells after being treated in the ALPHA2 trial...
Lone Patient Outcome Prompts FDA Hold on ALPHA2 CAR-T Trial
October 15, 2021

Healthy Lifestyle Reduces Risk of Incident Systemic Lupus Erythematosus

By Dave Quaile, MD /alert Contributor
The risk of systematic lupus erythematous may be reduced by almost half by adhering to modifiable healthy lifestyle behaviors according to new research...
Healthy Lifestyle Reduces Risk of Incident Systemic Lupus Erythematosus
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Racially segregated schooling tied to worse late-life cognition

By Marilynn Larkin NEW YORK (Reuters Health) - Late-life cognitive capabilities, particularly executive function and semantic memory, are likely worse among Black individuals who experienced racially Read More »

Biden signs order imposing new international travel vaccine rules, lifting restrictions

By David Shepardson (Reuters) U.S. President Joe Biden on Monday signed an order imposing new vaccine requirements for most foreign national air travelers and lifting severe travel restrictions on Read More »

Surgery needed in nearly half of appendicitis patients treated with antibiotics

By Reuters Staff (Reuters Health) - Antibiotic therapy can prevent or delay the need for an appendectomy, but ultimately nearly half of the patients will eventually require the surgery, according to Read More »

Belimumab after rituximab a promising therapeutic strategy for lupus

By Megan Brooks NEW YORK (Reuters Health) – Treatment with belimumab after rituximab reduced serum IgG anti-dsDNA antibody levels and risk for severe flares in patients with systemic lupus Read More »

Delta variant does not appear to make children sicker

By Reuters Staff (Reuters) - The Delta variant of the coronavirus does not appear to cause more severe disease in children than earlier forms of the virus, a UK study suggests. Earlier this year, the Read More »

Vaccines weaker than expected in multiple myeloma patients

By Reuters Staff (Reuters) - A new study sheds light on the vulnerability of multiple myeloma patients to the coronavirus. The study, released online on in Cancer Cell, reveals these patients not only Read More »

Cannabis vaping among adolescents soaring

By Linda Carroll (Reuters Health) - The lifetime prevalence of cannabis vaping among teens and preteens in the U.S. and Canada doubled between 2013 and 2020, while "past 12-month" use nearly doubled Read More »

COVID-19 vaccines not linked with pregnancy loss

By Reuters Staff (Reuters) - Two studies in major medical journals add to evidence that COVID-19 vaccines are safe before and during pregnancy. One study, published in The New England Journal of Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information